Patients with a higher number (above 25th percentile) of CD34+/KDR+ and CD34+/VE-cadherin+ and lower of CD14+/endoglin+ cells (equal or below 75th percentile) were younger, with less years since diagnosis of hypertension, and with lower BP. The gene discussed is CDH5; the disease is hypertensive disorder.